Aug 7, 2026·5 min readCharles River Rose 12% — the Pharma Outsourcing Cycle Is TurningRuslan Averin on Charles River Q2 2026: stronger-than-expected results, raised full-year guidance, and what CROs signal about pharma R&D budgets.
